STAT3 inhibition can promote apoptosis in cancer cells and prevent tumor growth [168], but it may also enhance the aggressiveness of HCC tumors by increasing the expression of EMT‐related proteins [169]. This evidence concerns the gene STAT3 and hepatocellular carcinoma.